Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2
Creator
Liu, Yan
Wang, Chuang
Ding, Hui
Cheng, Jianwei
Ding, Fengjiao
Ke, Tianyi
Lao, Fang
Ouyang, Fangxing
Wang, Xiaofei
Xi, Lun
Yan, Xichong
Yao, Dehui
Zhang, Rongkun
Zhang, Zeyi
Source
BioRxiv
abstract
The outbreak of COVID-19 has so far inflicted millions of people all around the world and will have a long lasting effect on every aspect of everyone’s life. Yet there is no effective approved treatment for the disease. In an effort of utilizing human ferritin as nanoplatform for drug delivery, we engineered a fusion protein by presenting receptor-binding motif (RBM) of SARS-CoV-2 virus spike glycoprotein on the N-terminus of ferritin subunits. The designed fusion protein with a cage-like structure, similar to that of corona virus, is a potential anti-SARS-CoV-2 vaccine. We hereby show the construction, preparation, and characterization of the fusion protein RBM-HFtn. Our initial affinity study confirmed its biological activity towards ACE2 receptor which suggests its mode of action against SARS-CoV-2 could be either through vaccine therapy or blocking the cellular entry of virus as antagonist of ACE2 receptor.
has issue date
2020-06-08
(
xsd:dateTime
)
bibo:doi
10.1101/2020.05.25.115618
has license
biorxiv
sha1sum (hex)
ff4e9c2e98b87f2a1c4837824b29079774cba73d
schema:url
https://doi.org/10.1101/2020.05.25.115618
resource representing a document's title
Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2
schema:publication
bioRxiv
resource representing a document's body
covid:ff4e9c2e98b87f2a1c4837824b29079774cba73d#body_text
is
schema:about
of
named entity 'IS A'
named entity 'STRUCTURE'
named entity 'LIFE'
named entity 'BINDING'
named entity 'CONFIRMED'
named entity 'VIRUS'
covid:arg/ff4e9c2e98b87f2a1c4837824b29079774cba73d
named entity 'SARS-CoV-2 virus'
named entity 'ACE2 receptor'
named entity 'receptor'
named entity 'mode of action'
named entity 'SARS-CoV-2'
named entity 'SARS-CoV-2'
named entity 'glycoprotein'
named entity 'glycoprotein'
named entity 'binding affinity'
named entity 'refolding'
named entity 'polypeptide'
named entity 'SARS-CoV-2'
named entity 'protein assembly'
named entity 'conformation'
named entity 'ACE2 receptor'
named entity 'fusion protein'
named entity 'antibodies'
named entity 'ferritin'
named entity 'RBD'
named entity 'MERS-CoV'
named entity 'RBD'
named entity 'virus'
named entity 'inclusion bodies'
named entity 'refold'
named entity 'heavy chain'
named entity 'angiotensin-converting enzyme 2'
named entity 'Beijing'
named entity 'lysis'
named entity 'ferritin'
named entity 'outbreak in China'
named entity 'goat'
named entity 'glycoprotein'
named entity 'vaccine'
named entity 'immunogenicity'
named entity 'polypeptide'
named entity 'structural proteins'
named entity 'protein vaccines'
named entity 'glycoprotein'
named entity 'RBD'
named entity 'ACE2 receptor'
named entity 'antibody'
named entity 'BSA'
named entity 'receptor antagonist'
named entity 'ferritin'
named entity 'ACE2 receptor'
named entity 'protein'
named entity 'transition state'
named entity 'heavy chain'
named entity 'virion'
named entity 'sequence similarity'
named entity 'Antibodies'
named entity 'Secondary antibody'
named entity 'Ferritin'
named entity 'ACE2 receptor'
named entity 'clinical studies'
named entity 'ACE2'
named entity 'binding site'
named entity 'lungs'
named entity 'virus'
named entity 'Ferritin'
named entity 'Millipore'
named entity 'vaccine'
named entity 'lymph node'
named entity 'ACE2'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 4
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software